News
Goldman Sachs has launched an internal AI tool for workers. The launch of GS AI Assistant is behind the company firewall for ...
The GS Small Cap Equity Insights Fund returned -9.83% in the first quarter of 2025, underperforming its benchmark Index.
Goldman Sachs announces firmwide launch of GS AI Assistant, a generative AI tool that securely accesses AI models to help ...
The company said it will use the funding to advance adoption of the Canton Network, a blockchain for financial institutions.
Goldman Sachs on Monday announced a firmwide launch of an artificial intelligence assistant, a tool driven by generative AI, ...
Explore Goldman Sachs' top 5 Indian pharma stock picks with up to 36% upside - see the full recommendations now!
4don MSN
Goldman Sachs updated its Sharpe Ratio basket, a list of 50 stocks with the highest expected risk-adjusted returns in the ...
The dollar is likely to extend its worst start to a year as foreign investors boost their currency hedges, according to Richard Chambers, global head of repo-trading at Goldman Sachs Group.
1d
24/7 Wall St. on MSN5 Goldman Sachs S&P 500 Dividend Picks With the Highest Prospective Risk-Adjusted ReturnsThese five top stocks all make sense for growth and income investors looking for a performance edge for the rest of 2025 and ...
XPeng Inc. (NYSE:XPEV) is one of Goldman Sachs’ top Chinese stock picks. On June 17, Goldman Sachs upgraded the stock to a ...
China+1 strategy gains momentum in pharma, but full monetisation still 2-3 years away: Goldman Sachs
Indian pharmaceutical and biotech sectors benefit from global shift away from China, as per recent Goldman Sachs report.
The GS Small Cap Value Insights Fund returned -8.74% in the first quarter of 2025, underperforming its benchmark Index. Click ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results